Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biotage® EVOLUTE® EXPRESS 96-Well Plates

Published: Monday, September 17, 2012
Last Updated: Monday, September 17, 2012
Bookmark and Share
Biotage® introduces EVOLUTE® EXPRESS, a novel family of 96-well plates that simplify polymer-based SPE by employing a streamlined 3-step protocol; Load-Wash-Elute.

This novel approach removes the conditioning and equilibration steps that are necessary with traditional bio-analytical SPE procedures. Dramatically reducing the processing and method development times without loss of analyte recovery or method robustness.

The EVOLUTE® EXPRESS design provides a uniform flow in the processing of aqueous samples and eliminates the need to re-run samples due to well-clogging. This clear flow technology makes EVOLUTE® EXPRESS particularly efficient and effective when used with SPE automated systems whilst adding a distinct advantage by allowing consistent, rapid and reliable manual processing of the plates.

“Biotage has built a reputation for offering products that simplify Sample Preparation, promoting high throughput and reliability. This new product addresses a real concern for many analysts who have to re-run samples due to well-clogging and sample variability. The minimal 3-step approach of Load-Wash-Elute will considerably improve the way SPE is performed and offer significant time savings for all bio-analysis labs” says Gavin Jones, Sample Preparation Product Manager, Biotage.

EVOLUTE® EXPRESS 96-well plates are packed with polymer-based EVOLUTE® chemistries (ABN, CX, WCX, AX and WAX) to address most application needs, and a new sorbent selection plate for screening and method development has been added. 


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biotage and Peptide Synthesis
CEM claim to won a “patent dispute” with Biotage.
Tuesday, May 14, 2013
New Methods for the Extraction of Key Compounds for Clinical, Environmental and Forensic Applications
A new series of application notes utilizing the industry-standard RapidTrace® SPE Workstation for medicinal and analytical chemistry have been released.
Monday, January 10, 2011
Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences
Biotage announces the second installment in its series of webinars focusing on peptide synthesis.
Friday, October 29, 2010
Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second installment in its series of webinars focusing on peptide synthesis.
Wednesday, October 27, 2010
Biotage Announces Research Collaboration with University of Copenhagen for Peptide Synthesis
Collaborations aims to develop new applications on the Biotage Syro Wave in the field of synthetic peptide and protein chemistry.
Thursday, May 13, 2010
Biotage Awarded Patent for Flash Purification Method Development and Optimization
The Company has been awarded U.S. patent 7686959: Control system and Method for Flash Separation.
Wednesday, April 21, 2010
Biotage Introduces EVOLUTE WCX: Now Providing a Total Solution for Basic Compounds
Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the further expansion of its successful family of products with the launch of Evolute WCX.
Wednesday, March 17, 2010
Biotage Joins Forces with MultiSynTech and Enters the Peptide Synthesis Business
Biotage enters agreements concerning both the distribution rights for MultiSynTechs systems and the establishment of a joint development project.
Tuesday, February 24, 2009
Biotage Makes a Change in Top Management after Business Area President Resigns
David Patteson, President of the business area Discovery Chemistry will leave the company on 1 April 2006.
Tuesday, February 28, 2006
Biotage Receives its Largest Order to Date
Instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.
Friday, August 12, 2005
Biotage expands European presence

Wednesday, April 09, 2003
Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
New Diabetes Drug has Unexpected Side Effect
A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to new research.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Cannabis May Be Used to Treat Fractures
TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!